AATB recognizes that many AATB-accredited tissue establishments have SOPs, forms, and other records that reference the association’s former name.

AATB is excited to announce our continued collaboration with Medline Industries, LLC, through the AATB-Medline Affinity Program, delivering added value and cost savings to our accredited members.

Registration for the 2026 AATB Webinar Series Subscription is open! This comprehensive learning opportunity provides unlimited access to 30+ live, 60-minute webinars and 130+ on-demand sessions, designed to support your ongoing professional development and expertise in tissue banking.

Effective January 1, AATB transitioned from a 501(c)(3) nonprofit membership association to a 501(c)(6) trade association and now operates as the Association for Advancing Tissue and Biologics (AATB).

On Wednesday, December 24, the Centers for Medicare and Medicaid Services (CMS) announced the withdrawal of the final Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs).

AATB is pleased to announce the release of an updated version of the Sepsis Pilot Study Report, originally published in September 2024.

AATB members have voted to approve the proposal to repeal and replace the AATB Bylaws.

AATB is excited to invite all AATB members to participate in our Capitol Hill Fly-In on February 25, 2026.

We’re excited to share a new way to engage with the topics that matter most to our community.